ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
62,972.42
-1.20%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Basilea Pharmaceutica Ag (0QNA) Quote

Basilea Pharmaceutica Ag

Basilea Pharmaceutica Ag (0QNA)

LSE
46.20
0.00
(0.00%)
Closed April 27 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
46.20
Bid
45.05
Ask
47.35
Volume
3,175
0.00 Day's Range 0.00
46.20 52 Week Range 46.20
Market Cap
533.489M
Previous Close
46.20
Open
-
Last Trade
609
@
40.6
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,611
Shares Outstanding
12,002,000
Dividend Yield
-
PE Ratio
51.05
Earnings Per Share (EPS)
0.87
Revenue
150.28M
Net Profit
10.45M

About Basilea Pharmaceutica Ag

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.basilea.com
Headquarters
Basel, Che
Founded
1970
Basilea Pharmaceutica Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QNA. The last closing price for Basilea Pharmaceutica was CHF46.20. Over the last year, Basilea Pharmaceutica shares have traded in a share price range of CHF 46.20 to CHF 46.20.

Basilea Pharmaceutica currently has 12,002,000 shares outstanding. The market capitalization of Basilea Pharmaceutica is CHF533.49 million. Basilea Pharmaceutica has a price to earnings ratio (PE ratio) of 51.05.

0QNA Latest News

More News

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Basilea shareholders approve all proposals of the board of directors at the annual general meeting Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a...

April 24 2024
UK Regulatory

Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats

Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats Allschwil, 24. April 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches...

April 24 2024
UK Regulatory

Basilea erhält CARB-X-Förderung für die Entwicklung einer kürzlich erworbenen neuen Antibiotika-Wirkstoffklasse

Basilea erhält CARB-X-Förderung für die Entwicklung einer kürzlich erworbenen neuen Antibiotika-Wirkstoffklasse Allschwil, 09. April 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein...

April 09 2024
UK Regulatory

Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics

Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics Allschwil, Switzerland, April 09, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage...

April 09 2024
UK Regulatory

Basilea gibt Erhalt der US-FDA-Zulassung für Antibiotikum ZEVTERA® (Ceftobiprol-Medocaril) für drei Indikationen bekannt

Basilea gibt Erhalt der US-FDA-Zulassung für Antibiotikum ZEVTERA® (Ceftobiprol-Medocaril) für drei Indikationen bekannt Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, 04. April 2024 Basilea...

April 04 2024
UK Regulatory

Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications

Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, April 04, 2024 Basilea...

April 04 2024
UK Regulatory

Anhaltend gute Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus

Anhaltend gute Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus Allschwil, 11. März 2024 Basilea Pharmaceutica AG, Allschwil (SIX:...

March 11 2024
UK Regulatory

Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea

Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea Allschwil, Switzerland, March 11, 2024 Basilea Pharmaceutica Ltd...

March 11 2024
UK Regulatory

Basilea reports strong 2023 full-year results with profitability significantly above guidance, whilst substantially expanding the R&D portfolio

Basilea reports strong 2023 full-year results with profitability significantly above guidance, whilst substantially expanding the R&D portfolio Increased Cresemba® and Zevtera®-related revenue...

February 13 2024
UK Regulatory

Basilea meldet starkes Gesamtjahr 2023 mit einer über der Guidance liegenden Profitabilität trotz substanziell erweitertem F&E-Portfolio

Basilea meldet starkes Gesamtjahr 2023 mit einer über der Guidance liegenden Profitabilität trotz substanziell erweitertem F&E-Portfolio Anstieg der Cresemba®- und Zevtera®-basierten Umsätze...

February 13 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10046.246.246.2401446.2DE
40046.246.246.2420846.2DE
120046.246.246.2261146.2DE
260046.246.246.2477646.2DE
520046.246.246.2444846.2DE
1560046.246.246.2480646.2DE
2600046.246.246.2400246.2DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
Kam8 Kam8 4 minutes ago
I have been in nwbo 9 years.
NWBO
Brokemillwright Brokemillwright 6 minutes ago
Hahahahahah you say they are applying for OTC after getting booted from NASDAQ like it's a good thing lol! Couldn't make the cut there so try a good ol downgrade and fool the greater fools is what's your saying right??
ENZC
quester614 quester614 8 minutes ago
Speaking of old news. Why is this newsletter about Nexboard recent developments still referring to 35,000 homes being built. That changed to 29,000 some time ago. Really impressive the homes being built for PPL with such little income. NNC and XERI need to build in the US to solve our homeless probl
XERI
Kam8 Kam8 11 minutes ago
Don't fool me. Ok
NWBO
lodas lodas 12 minutes ago
The borrowers and the FDIC was harmed by LIBOR, not WAMU... why?... WAMU just passed the higher interest rates to those that took out loans... The FDIC was harmed because they were over insuring the Liabilities of the WAMU banks and was not being compensated from the fees they got from the banks...
COOP
rikkie rikkie 15 minutes ago
Great, on Monday you can buy even more shares of a future top company.
Please don't forget this because you are running out of time!
LWLG
sicofbs sicofbs 20 minutes ago
Restricted .. yes why would they want them now🤔… could have done that anytime after accepted filings
IGPK
uber darthium uber darthium 22 minutes ago
Hey Defamations, how about that 1,161,528,192 shares outstanding updated tonight

A cool 25 million added to the undiluted OS

over 2,323,056,384 shares outstanding fully diluted (Series A)

THAT IS ALMOST 2.325 BILLION SHARES OUTSTANDING FULLY DILUTED (Seri
SHMP
The Night Stalker The Night Stalker 23 minutes ago
just needs love
CAVR
Polymer Paul Polymer Paul 23 minutes ago
Happy to share my order was filled too. I'm back. After a meeting with lebby in Wales he changed my mind because his eyes had a glisten to them and he smelt like roses with a hint of citrus. Total game changer. He ooozed deals and revenue. Was truly a magnificent sight to behold!
LWLG
littlejohn littlejohn 24 minutes ago
Houthi rebels hit dark fleet Russian tanker...

https://www.bbc.com/news/world-middle-east-68909912

They are getting better if they

can hit dark fleet ships...

Or either Russia gave them the

coordinates to make the hit...
Jimmy Joe Jimmy Joe 24 minutes ago
TopJetFuel busted again. Awwwwwww

Hard to keep the monikers straight. 😅😆😂

$DBMM baby~!
DBMM
The Night Stalker The Night Stalker 25 minutes ago
up a tick this week
PWDY
4u2nv2 4u2nv2 29 minutes ago
Hey old friend. If we can both prove we are not in a federal prison for too much drinking and banging college chicks? I hope you have the same cell number because I am texting you soon. You remember that nice talking lady at Bizm3? You were so right about what she liked to do. The times we had back
MCIC
arizona1 arizona1 31 minutes ago
This song always makes me cry.

[yt]2LuGzwNy2ws[/yt]
The Night Stalker The Night Stalker 32 minutes ago
https://stockcharts.com/h-sc/ui?s=gmzp&p=W&yr=1&mn=6&dy=0&id=p24986097784&listNum=23&a=1113701411
GMZP
4u2nv2 4u2nv2 33 minutes ago
Are you still alive??? This was some BS here. I am curious is you are still around?
BDEZ BDEZ 33 minutes ago
Russia says it has almost completely stopped using the dollar in mutual trade with China.

Both are stockpiling gold.
BeachBum BeachBum 34 minutes ago
Once this starts is not a high standard. The CEO f’ed up and created an environment where it isn’t trading. He is clearly no genius. I think he knows he screwed up traveling without finalizing the report and releasing before the deadline. There is nothing good about what is happening. He stopped upd
AHRO
4u2nv2 4u2nv2 35 minutes ago
Could this be restarted?
TURA
JonasBelgium JonasBelgium 35 minutes ago
I think it is time for a new alias chart
reader... After one day every body did know already you are a payed basher.

Ask Tedpeele how to make a new alias, it is easy 😂.

You think we will sell if it goes down... Wrong... We buy every time we can again..
LWLG
CoinOp CoinOp 36 minutes ago
$EBET 📢 Huge step up as on high watch for removal of motion to dismiss which will pave the way to, as I see it - Discovery Phase of Trial, Buyout, or Settlement Talks $$. ↗️ Further in to trial brings the likelihood of even higher $$ possible. Aristocrat Leisure can pay top $$📢
EBET
CoinOp CoinOp 36 minutes ago
$EBET 📢 Huge step up as on high watch for removal of motion to dismiss which will pave the way to, as I see it - Discovery Phase of Trial, Buyout, or Settlement Talks $$. ↗️ Further in to trial brings the likelihood of even higher $$ possible. Aristocrat Leisure can pay top $$📢
EBET
4u2nv2 4u2nv2 36 minutes ago
This was kicked to the expert market and basically dead. Not unless a very large shareholder wants to do the impossible. They were selling bonds and milking that angle. I always wondered why Victor moved on an OTC Shell but nothing happened with this one? No one cared back then. So, why would anythi
TURA

Your Recent History

LSE
0QNA
Basilea Pharmaceutica
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved